Acurx PharmaceuticalsACXP
13F holders, Q3 2025 (September 30)16holders +15
4new positions
0sold out
$4.38avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, up 15 from Q2 2025. 4 opened new positions and 0 sold out. The largest holders were Prospect Financial Services LLC ($85K), Susquehanna International Group, LLP ($72K) and Sabby Management, LLC ($37K).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $3K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 23,658 shares bought and 806 shares sold, net +22,853 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Prospect Financial Services LLC | 0.05% | Add +28.5% | 19,883 | $85K |
| Susquehanna International Group, LLP | 0.00% | Add +362.5% | 16,815 | $72K |
| Sabby Management, LLC | 0.20% | Add +103.9% | 8,705 | $37K |
| Morgan Stanley | 0.00% | Reduce -4.1% | 5,310 | $23K |
| Lanark Financial, Inc. | 0.00% | Reduce -4.1% | 1,500 | $6K |
| Cornerstone Planning Group LLC | 0.00% | Reduce -59.9% | 67 | $5K |
| GPS Wealth Strategies Group, LLC | 0.00% | No change | 1,225 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +397.3% | 1,077 | $5K |
| Citigroup Inc. | 0.00% | New | 453 | $2K |
| Group One Trading LLC | 0.00% | Reduce -58.0% | 298 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 242 | $1K |
| Bank of America Corp. | 0.00% | Add +0.9% | 71 | $304 |
| BlackRock, Inc. | 0.00% | Reduce -4.4% | 60 | $257 |
| Advisory Services Network, LLC | 0.00% | New | 59 | $253 |
| Wealthspire Advisors, LLC | 0.00% | New | 15 | $65 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -12.2% | 13 | $56 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.